Editas Medicine (EDIT) Short Interest Ratio & Short Volume → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free EDIT Stock Alerts $5.56 +0.52 (+10.32%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Editas Medicine Short Interest DataCurrent Short Volume18,760,000 sharesPrevious Short Volume16,360,000 sharesChange Vs. Previous Month+14.67%Dollar Volume Sold Short$114.06 millionShort Interest Ratio / Days to Cover9.8Last Record DateApril 15, 2024Outstanding Shares82,235,000 sharesPercentage of Shares Shorted22.81%Today's Trading Volume2,717,539 sharesAverage Trading Volume1,843,758 sharesToday's Volume Vs. Average147% Short Selling Editas Medicine ? Sign up to receive the latest short interest report for Editas Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEDIT Short Interest Over TimeEDIT Days to Cover Over TimeEDIT Percentage of Float Shorted Over Time Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. Editas Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202418,760,000 shares $114.06 million +14.7%N/A9.8 $6.08 3/31/202416,360,000 shares $121.39 million +17.4%N/A8.9 $7.42 3/15/202413,930,000 shares $113.25 million +3.0%N/A7.5 $8.13 2/29/202413,520,000 shares $136.01 million +7.4%N/A7 $10.06 2/15/202412,590,000 shares $104.62 million +3.1%N/A7.2 $8.31 1/31/202412,210,000 shares $85.84 million -2.2%N/A6.7 $7.03 Get the Latest News and Ratings for EDIT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Editas Medicine and its competitors with MarketBeat's FREE daily newsletter. 1/15/202412,480,000 shares $113.19 million -2.4%N/A6.8 $9.07 12/31/202312,790,000 shares $129.56 million -14.6%N/A7 $10.13 12/15/202314,970,000 shares $163.62 million -5.1%N/A7.7 $10.93 11/30/202315,780,000 shares $166.16 million -0.6%N/A8.9 $10.53 11/15/202315,870,000 shares $140.29 million -5.4%N/A9.7 $8.84 10/31/202316,770,000 shares $112.02 million +2.1%N/A11 $6.68 10/15/202316,420,000 shares $115.76 million +2.8%N/A11.2 $7.05 9/30/202315,970,000 shares $124.57 million +5.2%N/A11.1 $7.80 9/15/202315,180,000 shares $127.36 million +4.7%N/A10.8 $8.39 8/31/202314,500,000 shares $129.20 million +0.6%N/A8.1 $8.91 8/15/202314,410,000 shares $126.23 million -6.7%N/A7.5 $8.76 7/31/202315,440,000 shares $135.56 million -0.2%N/A7.5 $8.78 7/15/202315,470,000 shares $133.20 million -20.4%N/A7.4 $8.61 6/30/202319,430,000 shares $159.91 million -5.8%N/A8.6 $8.23 6/15/202320,630,000 shares $191.45 million +0.6%N/A9 $9.28 5/31/202320,500,000 shares $188.19 million +1.3%N/A11 $9.18 5/15/202320,230,000 shares $202.50 million +7.3%N/A11 $10.01 4/30/202318,860,000 shares $153.90 million -5.5%N/A10.7 $8.16 4/15/202319,950,000 shares $151.42 million +1.5%N/A11.1 $7.59 3/31/202319,650,000 shares $142.46 million -4.8%N/A11.3 $7.25 3/15/202320,640,000 shares $174.00 million +7.7%N/A11.9 $8.43 2/28/202319,160,000 shares $173.21 million -2.6%N/A10 $9.04 2/15/202319,670,000 shares $203.78 million -6.1%N/A10.2 $10.36 1/31/202320,940,000 shares $207.10 million -5.4%N/A10.5 $9.89 1/15/202322,140,000 shares $186.64 million +2.3%N/A11.8 $8.43 12/30/202221,650,000 shares $192.04 million +2.3%N/A12 $8.87 12/15/202221,170,000 shares $211.91 million +7.7%N/A12.3 $10.01 11/30/202219,650,000 shares $208.29 million +4.0%N/A11.7 $10.60 11/15/202218,900,000 shares $246.65 million +2.3%N/A12.1 $13.05 10/31/202218,470,000 shares $231.80 million -0.4%N/A12.1 $12.55 10/15/202218,540,000 shares $210.99 million +2.2%N/A11.8 $11.38 9/30/202218,150,000 shares $222.16 million +5.3%N/A11 $12.24 9/15/202217,240,000 shares $277.74 million +3.4%N/A10.1 $16.11 8/31/202216,680,000 shares $245.20 million +2.7%N/A9.6 $14.70“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. EDIT Short Interest - Frequently Asked Questions What is Editas Medicine's current short interest? Short interest is the volume of Editas Medicine shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 18,760,000 shares of EDIT short. Learn More on Editas Medicine's current short interest. What is a good short interest ratio for Editas Medicine? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDIT shares currently have a short interest ratio of 10.0. Learn More on Editas Medicine's short interest ratio. Which institutional investors are shorting Editas Medicine? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Editas Medicine: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Editas Medicine's short interest increasing or decreasing? Editas Medicine saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 18,760,000 shares, an increase of 14.7% from the previous total of 16,360,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Editas Medicine's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Editas Medicine: C4 Therapeutics, Inc. (13.89%), Taysha Gene Therapies, Inc. (8.59%), Adaptive Biotechnologies Co. (7.23%), Voyager Therapeutics, Inc. (6.36%), iTeos Therapeutics, Inc. (7.43%), Lexeo Therapeutics, Inc. (5.21%), Fate Therapeutics, Inc. (16.62%), Allogene Therapeutics, Inc. (29.95%), Alector, Inc. (9.48%), Replimune Group, Inc. (18.75%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Editas Medicine stock? Short selling EDIT is an investing strategy that aims to generate trading profit from Editas Medicine as its price is falling. EDIT shares are trading up $0.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Editas Medicine? A short squeeze for Editas Medicine occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EDIT, which in turn drives the price of the stock up even further. How often is Editas Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDIT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: C4 Therapeutics Short Squeeze Taysha Gene Therapies Short Squeeze Adaptive Biotechnologies Short Squeeze Voyager Therapeutics Short Squeeze iTeos Therapeutics Short Squeeze Lexeo Therapeutics Short Squeeze Fate Therapeutics Short Squeeze Allogene Therapeutics Short Squeeze Alector Short Squeeze Replimune Group Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDIT) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings